Asia-Pacific Precision. Global Sponsor Confidence.
NeurAsia is a Malaysia-headquartered, physician-led Contract Research Organisation (CRO) delivering high-quality, cost-effective clinical trials across Asia-Pacific.
We partner with biotech sponsors from the USA, UK, Europe, and Australia to accelerate their Phase 1–3 development programs through regional regulatory expertise, world-class data integrity, and unmatched operational agility.
Our global team operates with a sponsor-first mindset—offering tailored, compliant, and efficient solutions without the overhead of traditional Western CROs.
End-to-End Trial Management for Biotech Sponsors
Medical Writing
Clinical Project Management
Biostatistics
Data Management
Monitoring
Regulatory
Why Choose NeurAsia?
Up to 70% cost savings
IND-enabling and pivotal Phase 3 trial capability
In-house regulatory, biostatistics, PV, IMP, and monitoring teams
Schedule I & II IMP licensing, storage, and distribution
Decentralized trial (DCT) tools with full remote oversight
200% R&D tax deductions in Malaysia